Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;53(3):426-430.
doi: 10.1111/imj.16031. Epub 2023 Mar 15.

Central venous access device practice across haematology and oncology centres in Australia and New Zealand: a cross-sectional survey

Hiu L A Yuen  1   2 , Robert Weinkove  3   4   5 , Amanda Ullman  6   7   8 , Nicole Marsh  6   9   10 , Claire M Rickard  6   9   10   11 , Sanjeev Chunilal  1   2 , Zoe McQuilten  1   2
Affiliations

Central venous access device practice across haematology and oncology centres in Australia and New Zealand: a cross-sectional survey

Hiu L A Yuen et al. Intern Med J. 2023 Mar.

Abstract

Central venous access devices (CVADs) are commonly used in malignancies. We conducted an online, anonymous cross-sectional survey of practice regarding CVAD management in haematology centres among clinicians in Australia and New Zealand. We identified variation in clinical practice regarding CVAD selection, insertion, management and removal. These findings highlight research gaps in CVAD care.

Keywords: cannula; neoplasms; venous access devices.

PubMed Disclaimer

References

    1. idata. Vascular Access Devices Market Analysis, Size, Trends | Global | 2020-2026 | MedSuite 2020. Available from URL: https://idataresearch.com/product/vascular-access-devices-market/
    1. Smith RN, Nolan JP. Central venous catheters. Br Med J 2013; 347: f6570.
    1. Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, El-Rayes BF et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013; 31: 1357-70.
    1. Moss JG, Wu O, Bodenham AR, Agarwal R, Menne TF, Jones BL et al. Central venous access devices for the delivery of systemic anticancer therapy (CAVA): a randomised controlled trial. Lancet 2021; 398: 403-15.
    1. LeVasseur N, Stober C, Daigle K, Robinson A, McDiarmid S, Mazzarello S et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer - a survey of oncology nurses and physicians. Curr Oncol 2018; 25: 298-304.

LinkOut - more resources